Bowling, Kevin M.
Thompson, Michelle L.
Kelly, Melissa A.
Scollon, Sarah
Slavotinek, Anne M.
Powell, Bradford C.
Kirmse, Brian M.
Hendon, Laura G.
Brothers, Kyle B.
Korf, Bruce R.
Cooper, Gregory M.
Greally, John M.
Hurst, Anna C. E.
Funding for this research was provided by:
National Human Genome Research Institute (UO1HG007301, U01HG009599, U01HG006485)
Article History
Received: 15 June 2022
Accepted: 10 November 2022
First Online: 21 November 2022
Declarations
:
: The studies were carried out in accordance to the Declaration of Helsinki. The SouthSeq study was approved and monitored by the institutional review board at the University of Alabama at Birmingham (IRB-300000328). The KidsCanSeq study was approved by the Baylor College of Medicine Institutional Review Board (protocol H-42376). P<sup>3</sup>EGS was approved by the University of California at San Francisco IRB (17-22504). The Children’s of Alabama Genome Sequencing Study (COAGS) was approved and monitored by the Institutional Review Board at the University of Alabama at Birmingham (IRB-170314004).
: Written informed consent to publish the clinical details was obtained from all participants (parent, legal guardian, and/or child).
: The authors declare that they have no competing interests.